Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: A quantitative 31P-magnetic resonance spectroscopy and MRI study

Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: A quantitative 31P-magnetic resonance spectroscopy and MRI study

Show other versions (1)

Quantitative MRI and phosphorus magnetic resonance spectroscopy (31P-MRS) were used to investigate skeletal muscle metabolism in vivo in patients with dermatomyositis (DM) and polymyositis (PM) in order to evaluate the role of mitochondrial abnormalities in the pathogenesis and clinical expression o...

Full description

Bibliographic Details
Main Authors:	Cea, G, Bendahan, D, Manners, D, Hilton-Jones, D, Lodi, R, Styles, P, Taylor, D
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study.
by: Cea, G, et al.
Published: (2002)

Risk of cancer in dermatomyositis or polymyositis.
by: Hilton-Jones, D, et al.
Published: (1992)

Respiratory disorders in patients with polymyositis/dermatomyositis
by: Olga Alekseyevna Antelava, et al.
Published: (2014-03-01)

Polymyositis and dermatomyositis: Disease spectrum and classification
by: Siba P Raychaudhuri, et al.
Published: (2012-01-01)

Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach
by: Ha-Neul Jeong, et al.
Published: (2023-12-01)

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches.
by: Agnieszka Trybuch, et al.
Published: (2023-07-01)

Development of comorbid infection in patients with polymyositis/dermatomyositis
by: O A Antelava, et al.
Published: (2009-06-01)

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
by: Chester V. Oddis, et al.
Published: (2022-11-01)

Inflammatory Bowel Diseases Are Associated with Polymyositis and Dermatomyositis—A Retrospective Cohort Analysis
by: Kassem Sharif, et al.
Published: (2022-11-01)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
by: Stefano Palmucci, et al.
Published: (2022-11-01)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
by: mei liu, et al.
Published: (2023-11-01)

ANTISYNTHETASE SYNDROME IS THE MOST SEVERE SUBTYPE OF POLYMYOSITIS/DERMATOMYOSITIS:DESCRIPTION OF CASES
by: Olga Alekseyevna Antelava, et al.
Published: (2009-12-01)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
by: Yumiko Sugiyama, et al.
Published: (2018-01-01)

Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis
by: Sung Soo Ahn, et al.
Published: (2022-04-01)

Malignancy in a retrospective cohort of 17 patients with Dermatomyositis or Polymyositis in southern Tunisia
by: Sellami Khadija, et al.
Published: (2018-12-01)

KL-6 in adult polymyositis and dermatomyositis patients and its correlation with interstitial lung disease
by: Mayada Khalil, et al.
Published: (2023-12-01)

Prevalence of hearing loss, tinnitus, vertigo and sudden deafness among patients with polymyositis and dermatomyositis
by: Shih-Han Hung, et al.
Published: (2024-03-01)

T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis
by: Yasuhiro Shimojima, et al.
Published: (2017-11-01)

Clinical Characteristics and Associated Factors for Infection and in-Hospital Mortality in Inpatients with Polymyositis/Dermatomyositis in China: A Retrospective Study
by: Lao M, et al.
Published: (2023-01-01)

Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy.
by: Lodi, R, et al.
Published: (1998)

Intravoxel Incoherent Motion Diffusion-Weighted MRI, Fat Quantification, and Electromyography: Correlation in Polymyositis and Dermatomyositis
by: Hyunjung Kim, et al.
Published: (2024-03-01)

Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan
by: Qingqing Hu, et al.
Published: (2023-10-01)

Differential diagnosis of myopathic syndrome in dermatomyositis/polymyositis and progressive muscular dystrophies (description of a case)
by: Olga Alekseevna Antelava, et al.
Published: (2012-12-01)

Thymus variants on imaging of patients with primary Sjögren’s syndrome and polymyositis/dermatomyositis: clinical and immunological significance
by: Okinori Murata, et al.
Published: (2023-01-01)

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study
by: Shimojima Yasuhiro, et al.
Published: (2012-11-01)

Subclinical systolic and diastolic myocardial dysfunction in polyphasic polymyositis/dermatomyositis: a 2-year longitudinal study
by: Andrea Péter, et al.
Published: (2022-09-01)

Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis
by: Chenhang Ma, et al.
Published: (2024-03-01)

Involvement of YKL-40-positive macrophages commonly identified in polymyositis and dermatomyositis in the pathogenesis of myositis: a retrospective study
by: Kazuteru Noguchi, et al.
Published: (2024-01-01)

Muscle biopsies in dermatomyositis and polymyositis: practical relevance of analyzing different levels of histological sections of the same muscular compartment
by: Monica T. M. Diaz, et al.
Published: (2017-06-01)

Síndrome antifosfolípide e dermatomiosite/polimiosite: uma rara associação Antiphospholipid syndrome and dermatomyositis/polymyositis: a rare association
by: Fernando Henrique Carlos de Souza, et al.
Published: (2012-08-01)

Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy.
by: Isenberg, D, et al.
Published: (1986)

An Unusual Performance of Polymyositis
by: Yuqian Chu, et al.
Published: (2023-03-01)

A bibliometric analysis of the research status and trends in studies on polymyositis and dermatomyositis with interstitial lung disease from 2000 to 2022 using Web of Science
by: Xiao‐Na Ma, et al.
Published: (2024-02-01)

Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data
by: Pengyan Qiao, et al.
Published: (2023-01-01)

Investigation of muscle bioenergetics in the Marfan syndrome indicates reduced metabolic efficiency.
by: Crilley, J, et al.
Published: (2007)

Monoclonal antibodies to human leucocyte antigens in polymyositis and muscular dystrophy.
by: Rowe, D, et al.
Published: (1983)

Overlap Syndrome Consisting of Polymyositis/Dermatomyositis and ANCA-Associated Vasculitis According to the 2022 ACR/EULAR Criteria for Vasculitis: A Korean Single-Centre Study
by: Jang Woo Ha, et al.
Published: (2023-10-01)

Bacterial Efflux Pump Inhibitors Reduce Antibiotic Resistance
by: Lan Zhang, et al.
Published: (2024-01-01)

Isolated dysphagia due to polymyositis.
by: Palace, J, et al.
Published: (1993)

POLYMYOSITIS/DERMATOMIOSITIS: DIFFERENTIAL DIAGNOSIS
by: O. A. Antelava
Published: (2016-07-01)